Clinical trial · Observational
Human Papillomavirus (HPV) Type Distribution in Adult Women Diagnosed With Invasive Cervical Cancer in New Zealand
Hospital-based Epidemiological Study on the Distribution of Human Papillomavirus (HPV) Types in Adult Women Diagnosed With Invasive Cervical Cancer (ICC) in New Zealand
NCT01328028CI-TRIAL-00007890completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to assess the distribution of the most frequent types of human papillomavirus in women diagnosed with invasive cervical cancer in New Zealand.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Data collection | Other | — | UNRESOLVED |
| Testing of archived cervical cancer tissue samples | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Group A
- description
- Subjects diagnosed with invasive cervical cancer
- interventionNames
- Other: Testing of archived cervical cancer tissue samples
- Other: Data collection
Primary outcomes (1)
- measure
- Occurrence of HPV-16 and HPV-18 in women with invasive cervical cancer
- timeFrame
- At least the last 3 years from the time of study start
Secondary outcomes (3)
- measure
- Occurrence of other high-risk HPV types in women with invasive cervical cancer
- timeFrame
- At least the last 3 years from the time of study start
- measure
- Occurrence of HPV-16/ HPV-18 co-infection with other high-risk HPV types in women with invasive cervical cancer
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * A female aged 18 years and above at the time of cervical specimen collection, and currently residing in New Zealand. * Histological diagnoses of invasive cervical cancer stage IB or greater, within at least the last 3 years. * Written informed consent obtained from the subject/ next of kin/ Legally acceptable representative. * Availability of cervical specimen on which the diagnosis was made prior to any chemotherapy or radiotherapy. * The cervical specimen should be of appropriate size and with regular tissue specimens. * The cervical specimen should be adequately preserved. * All links to the subject's identity should be removed from the paraffin block. Exclusion Criteria: Not Applicable.
References
Publications (1)
- DERIVEDSykes P, Gopala K, Tan AL, Kenwright D, Petrich S, Molijn A, Chen J. Type distribution of human papillomavirus among adult women diagnosed with invasive cervical cancer (stage 1b or higher) in New Zealand. BMC Infect Dis. 2014 Jul 8;14:374. doi: 10.1186/1471-2334-14-374. PMID 25000939